Last reviewed · How we verify
Asclera
At a glance
| Generic name | Asclera |
|---|---|
| Sponsor | Massachusetts General Hospital |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
- Venous varices
Common side effects
- Injection site haematoma
- Injection site irritation
- Injection site discoloration
- Injection site pain
- Injection site pruritus
- Injection site warmth
- Neovascularisation
- Injection site thrombosis
Serious adverse events
- Anaphylactic shock
- Pulmonary embolism
- Deep vein thrombosis
- Cerebrovascular accident
- Cardiac arrest
- Circulatory collapse
- Loss of consciousness
- Angioedema
- Injection site necrosis
- Nerve injury
Key clinical trials
- Varithena Versus Endothermal Ablation of the Great Saphenous Vein (VERITAS) (PHASE4)
- Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins (NA)
- Caprini Score in Venous Surgery: a Prospective Cohort Study
- Comparative Study Between Sclerosing Agents Used in Treatment of Vascular Malformation (NA)
- Furosemide-Digoxin vs. Polidocanol for Cutaneous Warts (PHASE2)
- Polidocanol Foam With or Without Transdermal Laser for Varicose Veins: Randomized Clinical Trial (NA)
- Efficacy of the SALFOAM 3% Method Compared to the Conventional Polidocanol Foam Method (Tessari Method) for Treating Lower Limb Varicose Veins (NA)
- Efficacy of Skin Cooling in Reducing Pain Associated With Non-invasive Treatments of Neurofibromatosis Type 1 Cutaneous Neurofibromas (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Asclera CI brief — competitive landscape report
- Asclera updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI